NCT00684762View on ClinicalTrials.gov

Fasted Bioavailability Study of Cilostazol Tablets, 100 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Therapeutic Equivalency
Interventions
DRUG

Cilostazol 100 mg Tablets

Cilostazol (1 x 100 mg tablet) administered after an overnight fast of at least 10 hours

DRUG

Cilostazol (Pletal®) 100 mg Tablets

Cilostazol (Pletal® 1 x 100mg tablet) administered after an overnight fast of at least 10 hours.

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00684762 - Fasted Bioavailability Study of Cilostazol Tablets, 100 mg | Biotech Hunter | Biotech Hunter